Comment on: Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis. Reply.

Wang, Jinghua; Kong, Xiufang; Jin, Xuejuan; Jiang, Lindi

Wang, Jinghua; Kong, Xiufang; Jin, Xuejuan; Jiang, Lindi.

Afiliação

Wang J; Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Kong X; Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Jin X; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
Jiang L; Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.

Rheumatology (Oxford) ; 2024 Jan 17.

Article em En | MEDLINE | ID: mdl-38237922

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google